High proportion of drug hypersensitivity reactions to sulfasalazine following its use in anti-PD-1 associated inflammatory arthritis

Research output: Contribution to journal › Article › peer-review

9 Citations (Scopus)

172 Downloads (Pure)

Original language	English
Journal	Rheumatology
Early online date	13 Aug 2018
DOIs	https://doi.org/10.1093/rheumatology/key234
Publication status	E-pub ahead of print - 13 Aug 2018

Keywords

Ford_et_al_High_proportion_of_drug_hypersensitivity_Rheumatology_2018
Checked for eligibility 18/07/2018 This is a pre-copyedited, author-produced version of an article accepted for publication in Rheumaology following peer review. The version of record [insert complete citation information here] is available online at: xxxxxxx [insert URL and DOI of the article on the OUP website].
Accepted author manuscript, 381 KBLicence: Other (please specify with Rights Statement)

@article{06bba71c09b94fd38774536dda4e5981,

title = "High proportion of drug hypersensitivity reactions to sulfasalazine following its use in anti-PD-1 associated inflammatory arthritis",

keywords = "anti-PD-1, anti-PD-L1, pembrolizumab, melanoma, immune-related adverse event, arthritis",

author = "Mark Ford and Ilfita Sahbudin and Andrew Filer and Neil Steven and Benjamin Fisher",

year = "2018",

month = aug,

day = "13",

doi = "10.1093/rheumatology/key234",

language = "English",

journal = "Rheumatology",

issn = "1462-0324",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - High proportion of drug hypersensitivity reactions to sulfasalazine following its use in anti-PD-1 associated inflammatory arthritis

AU - Ford, Mark

AU - Sahbudin, Ilfita

AU - Filer, Andrew

AU - Steven, Neil

AU - Fisher, Benjamin

PY - 2018/8/13

Y1 - 2018/8/13

KW - anti-PD-1

KW - anti-PD-L1

KW - pembrolizumab

KW - melanoma

KW - immune-related adverse event

KW - arthritis

U2 - 10.1093/rheumatology/key234

DO - 10.1093/rheumatology/key234

M3 - Article

SN - 1462-0324

JO - Rheumatology

JF - Rheumatology

ER -